Biopharma Innovators Syntaxin Wins Top Honours at 2007 Interactive Media Awards
Biopharma firm Syntaxin's new website has won a very prestigious IMA award which recognises great design, technical innovation and accessibility compliance within the interactive media industry.
PR9.NET March 17, 2008 - London, UK - Cyber-Duck, an award winning web design company based in London and Hertfordshire offering corporate website design services, today announced that it has been awarded Outstanding Achievement in Website Development by the Interactive Media Awards for its work on the Syntaxin.com Website. The honour recognizes that the project met and surpassed the standards of excellence that comprise the web's most professional work. The site was honoured specifically for excellence in Medical and Science/Technology industries.
The judging consisted of various criteria, including design, usability, innovation in technical features, accessibility standards compliance and content. In order to win this award level, the site had to meet strict guidelines in each area - an achievement that very few websites submitted achieve.
Patrick Doyle, CEO of Syntaxin said, "Everyone at Syntaxin is delighted to be receiving this highly sought-after accolade as it reaffirms our belief that Syntaxin's new branding and website designed by Cyber-Duck better reflect Syntaxin as an industry leader. We hope that winning this award is simply the beginning of a fantastic 2008 in the biopharmaceutical and biotech industry for Syntaxin."
Award winning designers at Cyber-Duck commented, "We are extremely proud of the clean and professional look of the Syntaxin.com website design. Winning this award exemplifies how we managed to find the balance between powerful branding, eye-catching aesthetics, strong information architecture and accessibility compliancy."
See the award winning website design itself here: http://www.syntaxin.com
Or, visit the brand and website designers, Cyber-Duck here: http://www.cyber-duck.co.uk
# # #
Download PDF Version:
About Syntaxin Ltd
Syntaxin is a UK based biotech company focusing on biotech research and the development of new biopharmaceuticals and medicines for the treatment of a range of chronic diseases.
|Recent News Headlines
|Industry Category of Current Press Release